Dcm Advisors, LLC Bristol Myers Squibb CO Transaction History

Dcm Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $443,979 - $529,790	9,158 New	9,158 $469,000
Q2 2023 Sep 12, 2023	SELL	$63.71 - $70.74 $196,609 - $218,303	-3,086 Closed	0 $0
Q1 2023 Sep 12, 2023	SELL	$65.71 - $74.53 $7,293 - $8,272	-111 Reduced 3.47%	3,086 $213,000
Q4 2022 Sep 08, 2023	SELL	$68.48 - $81.09 $11,641 - $13,785	-170 Reduced 5.05%	3,197 $229,000
Q3 2022 Sep 08, 2023	SELL	$0.13 - $76.84 $860 - $508,911	-6,623 Reduced 66.3%	3,367 $239,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $725,473 - $799,000	9,990 New	9,990 $771,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $364,576 - $425,010	-6,798 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $205,260 - $240,436	3,469 Added 104.21%	6,798 $402,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $206,098 - $224,441	3,329 New	3,329 $222,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.